Dylan Curran

Dylan Curran

Auto-generated profile, based on publicly available information

Dylan Curran

WHOOP, Inc., Boston, Massachusetts, United States

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2026 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
DCDylan J Curran
Dylan J Curran
JLJosh Leota
Josh Leota
WHWilliam von Hippel
William von Hippel
FFFinnbarr Fielding
Finnbarr Fielding
CCChristopher J Chapman
Christopher J Chapman
GGGregory Grosicki
Gregory Grosicki
Background: Tobacco use remains a leading preventable cause of morbidity and mortality. Digital health tools and wearable technologies offer scalable opportunities for behavioral self-monitoring. However, real-world evidence characterizing long-term tobacco use trajectories and associated physiological changes during wearable adoption is limited. Objective: This study aims to characterize longitudinal trajectories of self-reported tobacco use during the first 72 weeks of wearable adoption and to examine associations between tobacco use and wearable-derived cardiopulmonary and sleep measures. Methods: We analyzed data from 12,678 new wearable members (18-79 years) who contributed up to 72 weeks of daily self-reported tobacco use and wearable-derived biometric data. Longitudinal trajectories of tobacco use were examined across prespecified 12-week quarters (Q1-Q6) using generalized linear mixed-effects models. Associations between tobacco use and wearable-derived nocturnal resting heart rate (RHR), heart rate variability (HRV), respiratory rate (RR), and sleep duration were evaluated using linear mixed-effects models that accounted for within- and between-person variation and adjusted for demographic and temporal covariates. Results: Across 3,765,573 person-days, the estimated daily probability of tobacco use declined from 55.1% (95% CI 53.8-56.4) during Q1 to 27.2% (95% CI 26.1-28.3) during Q6, representing an absolute reduction of 27.9 percentage points (95% CI –28.4 to –27.4). Among tobacco users with end-of-follow-up data, over one-quarter (1404/4975, 28.22%) reported no tobacco use during Q6. Greater logging engagement was associated with larger reductions in tobacco use; each 10-percentage-point increase in engagement corresponded to a 0.92-percentage-point greater decline from Q1 to Q6 (95% CI –1.58 to –0.26). Following tobacco use days, RHR was 1.71 beats/minute higher (95% CI 1.70-1.73), HRV was 3.54 ms lower (95% CI –3.59 to –3.49), RR was 0.19 breaths/minute higher (95% CI 0.19-0.20), and sleep duration was 9.78 minutes shorter (95% CI –10.08 to –9.49) relative to nonuse days. Reductions in tobacco use over time were associated with directionally favorable changes in RHR (P=.001), RR (P=.002), and sleep duration (P=.02). Conclusions: In this large-scale, observational, real-world study of wearable users, the probability of tobacco use declined over the first 72 weeks of adoption. Among participants with end-of-follow-up data, more than one-quarter reported no tobacco use during Q6. Tobacco use was consistently associated with less favorable cardiopulmonary and sleep measures, while reductions in tobacco use over time co-occurred with directionally favorable changes in these measures, although such changes may also reflect broader lifestyle or health changes. Overall, this study provides large-scale, longitudinal evidence that sustained reductions in tobacco use co-occur with favorable changes in physiological markers within a digital self-monitoring environment. As the findings derive from a single commercial ecosystem, independent replication in noncommercial, multiplatform settings will be needed to establish generalizability.

20 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
DCDylan Curran
Dylan Curran
WHWilliam von Hippel
William von Hippel
FFFinnbarr Fielding
Finnbarr Fielding
SJSummer R. Jasinski
Summer R. Jasinski
JLJosh Leota
Josh Leota
CCChristian P. Cheung
Christian P. Cheung
Background: Marijuana is among the most widely used controlled substances, with use rising as risk perception declines. Despite growing acceptance, concerns remain regarding its effects on cardiovascular and autonomic physiology, sleep, and risk of cannabis use disorder. Although laboratory and epidemiological studies have characterized these associations, objective evidence from real-world settings is limited. Methods: We studied cardiac autonomic function, sleep, and marijuana use patterns in 16,965 consumer-wearable device users, contributing a total of 5,226,739 person-days of data with or without self-reported use of marijuana. Linear mixed models related day-level use to nocturnal cardiac autonomic function (resting heart rate [RHR], heart rate variability [HRV]) and sleep (duration, fragmentation, architecture) at the within- and between-person levels. Binomial mixed models were used to estimate use probability across 72 weeks of marijuana tracking. Results: Members reported marijuana use on a median of 25.1% of logged days (IQR, 7.1–62.6%). Within individuals, use was associated with lower RHR (−0.12bpm; 99.5% CI: [−0.14, −0.10]) and lower HRV (−0.47ms [−0.53, −0.42]). Sleep was longer (+7.60min [7.37, 7.83]) but more fragmented, with more disturbances (+0.47 [0.45, 0.48]), greater wake time (+1.79min [1.70, 1.89]), and altered wearable-estimated sleep architecture. Daily use probability declined over 72 weeks (−11.1% [−11.5, −10.8]). Conclusions: Marijuana use was associated with altered nocturnal cardiac autonomic physiology and longer but more disrupted sleep. Marijuana use declined after commencing tracking, raising the possibility that longitudinal self-monitoring may influence use. These findings extend laboratory evidence on marijuana use to real-world settings and demonstrate the potential of consumer wearables for studying substance use and its physiological correlates at scale. Highlights: Marijuana-use nights were associated with lower resting heart rate and heart rate variability. Sleep was prolonged but more fragmented with marijuana use. Marijuana use fell over 72 weeks of wearable tracking.

15 April 2026 in JMIR Preprints
Verified
Preprint
Open access
DCDylan J Curran
Dylan J Curran
JLJosh Leota
Josh Leota
WHWilliam von Hippel
William von Hippel
FFFinnbarr Fielding
Finnbarr Fielding
CCChristopher J Chapman
Christopher J Chapman
GGGregory Grosicki
Gregory Grosicki
BACKGROUND Tobacco use remains a leading preventable cause of morbidity and mortality. Digital health tools and wearable technologies offer scalable opportunities for behavioral self-monitoring. However, real-world evidence characterizing long-term tobacco use trajectories and associated physiological changes during wearable adoption is limited. OBJECTIVE This study aims to characterize longitudinal trajectories of self-reported tobacco use during the first 72 weeks of wearable adoption and to examine associations between tobacco use and wearable-derived cardiopulmonary and sleep measures. METHODS We analyzed data from 12,678 new wearable members (18-79 years) who contributed up to 72 weeks of daily self-reported tobacco use and wearable-derived biometric data. Longitudinal trajectories of tobacco use were examined across prespecified 12-week quarters (Q1-Q6) using generalized linear mixed-effects models. Associations between tobacco use and wearable-derived nocturnal resting heart rate (RHR), heart rate variability (HRV), respiratory rate (RR), and sleep duration were evaluated using linear mixed-effects models that accounted for within- and between-person variation and adjusted for demographic and temporal covariates. RESULTS Across 3,765,573 person-days, the estimated daily probability of tobacco use declined from 55.1% (95% CI 53.8-56.4) during Q1 to 27.2% (95% CI 26.1-28.3) during Q6, representing an absolute reduction of 27.9 percentage points (95% CI –28.4 to –27.4). Among tobacco users with end-of-follow-up data, over one-quarter (1404/4975, 28.22%) reported no tobacco use during Q6. Greater logging engagement was associated with larger reductions in tobacco use; each 10-percentage-point increase in engagement corresponded to a 0.92-percentage-point greater decline from Q1 to Q6 (95% CI –1.58 to –0.26). Following tobacco use days, RHR was 1.71 beats/minute higher (95% CI 1.70-1.73), HRV was 3.54 ms lower (95% CI –3.59 to –3.49), RR was 0.19 breaths/minute higher (95% CI 0.19-0.20), and sleep duration was 9.78 minutes shorter (95% CI –10.08 to –9.49) relative to nonuse days. Reductions in tobacco use over time were associated with directionally favorable changes in RHR (P=.001), RR (P=.002), and sleep duration (P=.02). CONCLUSIONS In this large-scale, observational, real-world study of wearable users, the probability of tobacco use declined over the first 72 weeks of adoption. Among participants with end-of-follow-up data, more than one-quarter reported no tobacco use during Q6. Tobacco use was consistently associated with less favorable cardiopulmonary and sleep measures, while reductions in tobacco use over time co-occurred with directionally favorable changes in these measures, although such changes may also reflect broader lifestyle or health changes. Overall, this study provides large-scale, longitudinal evidence that sustained reductions in tobacco use co-occur with favorable changes in physiological markers within a digital self-monitoring environment. As the findings derive from a single commercial ecosystem, independent replication in noncommercial, multiplatform settings will be needed to establish generalizability.